Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation - Kreuz,W.; Gill,J.C.; Rothschild,C. (Thromb Haemost, 2005)